Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More May 1 2023 | Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More May 1 2023 | Heart Failure Awareness 365: Mental Health Patient News Heart Failure Awareness 365 Patient Resource Read More Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More Apr 26 2023 | New Episode of the Heart Failure Beat Discusses Equity in Heart Transplant HFSA News Podcasts Provider Education Read More Pagination First page « First Previous page ‹ Previous … Page 52 Page 53 Page 54 Page 55 Current page 56 Page 57 Page 58 Page 59 Page 60 … Next page Next › Last page Last »
May 9 2023 | FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients Industry News Industry Read More
May 1 2023 | Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America HFSA News Heart Failure Guidelines In The News Journal of Cardiac Failure Press Release Research Read More
May 1 2023 | Heart Failure Awareness 365: Mental Health Patient News Heart Failure Awareness 365 Patient Resource Read More
Apr 26 2023 | Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) Industry News In The News Industry Read More
Apr 26 2023 | New Episode of the Heart Failure Beat Discusses Equity in Heart Transplant HFSA News Podcasts Provider Education Read More
